BIIB
Biogen Inc
NASDAQ: BIIB · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$194.38
+6.00% today
Updated 2026-04-29
Market cap
$28.53B
P/E ratio
20.92
P/S ratio
2.88x
EPS (TTM)
$9.29
Dividend yield
—
52W range
$115 – $202
Volume
1.1M
Biogen Inc (BIIB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.37B | $8.55B | $8.63B | $8.48B | $8.55B | $8.09B | $9.05B | $10.13B | $11.86B | $14.32B | $19.50B | $22.88B | $23.65B | $25.29B | $27.23B | $24.62B | $23.88B | $24.55B | $26.84B | $28.05B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $1.62B | $1.71B | $2.37B | $2.46B | $2.48B | $2.54B | $2.98B | $3.24B | $3.18B | $4.67B | $6.70B | $8.73B | $7.87B | $7.64B | $8.38B | $6.89B | $7.86B | $9.79B | $6.86B | $7.46B |
| Total liabilities | $1.46B | $1.40B | $3.09B | $2.67B | $2.29B | $2.64B | $2.62B | $3.17B | $3.24B | $3.50B | $10.13B | $10.75B | $11.05B | $12.26B | $13.90B | $13.93B | $12.92B | $11.17B | $12.05B | $11.33B |
| Current liabilities | $583.04M | $582.86M | $2.19B | $923.22M | $714.94M | $1.05B | $912.89M | $1.66B | $1.76B | $2.22B | $2.58B | $3.34B | $3.37B | $3.30B | $4.86B | $3.74B | $4.30B | $3.27B | $3.43B | $5.53B |
| Long-term debt | $43.44M | $96.69M | $51.84M | $1.09B | $1.08B | $1.07B | $1.06B | $687.40M | $592.43M | $582.06M | $6.52B | $6.51B | $5.93B | $5.94B | $4.46B | $7.43B | $6.27B | $6.28B | $6.79B | $4.55B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-1.02B | $-860.83M | $-352.17M | $270.18M | $1.07B | $1.87B | $3.11B | $4.49B | $6.35B | $9.28B | $12.21B | $15.07B | $15.81B | $16.26B | $16.46B | $13.98B | $13.91B | $16.47B | $17.63B | $19.26B |
| Accounts receivable | $468.05M | $539.36M | $595.73M | $667.09M | $760.90M | $839.99M | $831.23M | $955.24M | $1.08B | $1.58B | $1.23B | $1.44B | $1.79B | $2.49B | $2.47B | $2.33B | $1.96B | $2.14B | $2.10B | $1.87B |
| Inventory | $182.81M | $169.10M | $233.99M | $263.60M | $293.95M | $289.07M | $326.84M | $447.37M | $659.00M | $804.02M | $893.40M | $1.00B | $902.70M | $929.90M | $804.20M | $1.07B | $1.35B | $1.34B | $2.53B | $2.46B |
| Goodwill | $1.13B | $1.15B | $1.14B | $1.14B | $1.14B | $1.15B | $1.15B | $1.20B | $1.23B | $1.76B | $2.66B | $3.67B | $4.63B | $5.71B | $5.76B | $5.76B | $5.76B | $5.75B | $6.22B | $6.48B |